REDWOOD CITY, Calif., July 16, 2014 /PRNewswire/ — Coherus BioSciences, Inc. announced the start of its Phase 3 trial of CHS-0214, a proposed biosimilar of etanercept (Enbrel®), in chronic plaque psoriasis (the RaPsOdy trial). This announcement …
Related posts
-
Latest on COVID-19 Case in Brunei Darussalam
The latest COVID-19 situation in Brunei Darussalam. No new case was reported yesterday. The Ministry... -
Two Suspects Detained In Murder Case
The Royal Brunei Police Force has conducted an investigation on a case related to a woman... -
Medical, Health and Beauty Treatment Services found in Violation of Medical and Health Practises Laws and Regulations
The Ministry of Health in cooperation with the Royal Brunei Police Force, RBPF, Royal Customs and...